Case-based analysis improves identification of Creutzfeldt–Jakob Disease in those misdiagnosed as Alzheimer's Disease.
Apply clinical features, neuroimaging, and biomarkers to improve identification of cases of probable or definite Creutzfeldt–Jakob Disease (CJD) that were initially misdiagnosed as rapidly progressive Alzheimer Disease (AD).
No takes yet. Share an insight, caveat, or question.
Elgenidi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: